Explore Articles and More on Our Blog
Keep up to date with the latest news on Saisei Group research, clinical trials, and MAF Series products.
Research Paper — Saisei Mirai
Saisei Mirai Featured in Science Featured – Telomere Research Recognized
Dr. Inui’s research on telomere length and aging has been featured in Science Featured, recognizing Saisei Mirai’s contributions to longevity and regenerative medicine.
The Effect of MAF Capsules and M Capsules on Lymphopenia and Clinical Outcomes in Non-Critical Hospitalized COVID-19 Patients
The Effect of MAF Capsules and M Capsules on Lymphopenia and Clinical Outcomes in Non-Critical Hospitalized COVID-19 PatientsPreprints with The Lancet 19 Pages Posted: 7 Feb 2023 Abstract BACKGROUND: Excessive inflammation and lymphopenia are linked to poor Covid-19 clinical outcomes. Targeting both conditions using an immunomodulating approach needs to be tested.METHODS: We conducted an open-label, randomized, controlled trial of MAF Capsules and M Capsules in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection but at enrolment did not require resuscitation or mechanical ventilation. Patients were randomly assigned to receive, in addition to standard of care...